Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-03 @ 7:10 AM
Study NCT ID:
NCT04806451
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-02-05
First Post:
2021-03-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
Sponsor:
Neurocrine Biosciences
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NBI-74788-CAH2006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None